RT Journal Article T1 Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration A1 Aguareles, José A1 Paraíso-Luna, Juan A1 Palomares, Belén A1 Bajo-Grañeras, Raquel A1 Navarrete, Carmen A1 Ruiz-Calvo, Andrea A1 García-Rincón, Daniel A1 García-Taboada, Elena A1 Guzmán, Manuel A1 Muñoz, Eduardo A1 Galve-Roperh, Ismael K1 Cannabinoid K1 Huntingtin K1 Neurodegeneration K1 Neurogenesis K1 PPAR K1 Cannabinoides K1 Proteína huntingtina K1 Enfermedades neurodegenerativas K1 Neurodegenerative diseases K1 Neurogénesis K1 Peroxisome proliferator-activated receptors K1 Receptores activados del proliferador del peroxisoma AB The administration of certain cannabinoids provides neuroprotection in models of neurodegenerative diseases by acting through various cellular and molecular mechanisms. Many cannabinoid actions in the nervous system are mediated by CB1 receptors, which can elicit psychotropic effects, but other targets devoid of psychotropic activity, including CB2 and nuclear PPARγ receptors, can also be the target of specific cannabinoids. PB BioMed Central Ltd. YR 2019 FD 2019-03-08 LK http://hdl.handle.net/10668/3148 UL http://hdl.handle.net/10668/3148 LA en NO Aguareles J, Paraíso-Luna J, Palomares B, Bajo-Grañeras R, Navarrete C, Ruiz-Calvo A, et al. Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration. Transl Neurodegener. 2019 Mar 8;8:9. DS RISalud RD Jun 14, 2025